HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$42.92
Day range
$41.21 - $43.40
Year range
$1.87 - $48.26
Market cap
4.56B USD
Avg Volume
4.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.72M | 11.14% |
Net income | -24.64M | -12.26% |
Net profit margin | — | — |
Earnings per share | -0.27 | 3.57% |
EBITDA | -27.70M | -11.46% |
Effective tax rate | -0.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 295.64M | -20.69% |
Total assets | 301.65M | -20.25% |
Total liabilities | 17.58M | 27.77% |
Total equity | 284.07M | — |
Shares outstanding | 90.08M | — |
Price to book | 13.21 | — |
Return on assets | -22.28% | — |
Return on capital | -23.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -24.64M | -12.26% |
Cash from operations | -19.77M | -20.16% |
Cash from investing | 24.50M | -22.83% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 4.73M | -97.35% |
Free cash flow | -12.57M | -31.21% |
About
Founded
2016
Headquarters
Website
Employees
59
